Professional Documents
Culture Documents
www.elsevier.com/locate/rigp
Abstract
Chronic pelvic pain (CPP) is a common problem with a prevalence of about 38/1000 among women aged 2050 years. The main
gynaecological diagnoses include endometriosis, pelvic inflammatory disease and adhesions. The most common gastrointestinal diagnosis is
irritable bowel syndrome and genitourinary diagnosis includes pathology such as interstitial cystitis. It is a challenge instigating the right
investigations for patients with chronic pelvic pain because there is a considerable symptom overlap. They also have a higher prevalence for
symptoms such as dysmenorrhea and dyspareunia. In this review, we aim to discuss the clinical consultation necessary to help us decide upon
which investigative tools we need to use to help diagnose the cause(s) of CPP, although one needs to stress that a specific cause may not be
found in patients with CPP and symptom focused multidisciplinary management of CPP is at least as important as diagnosis of specific
pathology and disease focused treatment.
# 2005 Elsevier B.V. All rights reserved.
Keywords: Chronic pelvic pain; Investigations; Ultrasound; Magnetic resonance imaging; Venography; Laparoscopy; Pelvic congestion syndrome;
Adhesions; Endometriosis; Adenomyosis
1. Introduction
Chronic pelvic pain (CPP) may be defined as a noncyclical pain of greater than 6 months duration that is
localised to the pelvis, anterior abdominal wall at or below
the umbilicus, the lumbosacral area, or buttocks, and is of
sufficient severity as to cause functional disability or lead to
medical care [1]. Pain is generally defined as an unpleasant
sensory and emotional experience associated with actual or
potential tissue damage. It is therefore most important for
health professions to appreciate the emotional and subjective
nature of pain, in particular CPP. Historically, gynaecologists have tended to discount pain symptoms with an undue
emphasis on visible pathology as validating the patients
experience.
CPP is a common problem: the prevalence of the
condition is about 38/1000 among women aged 2050 years,
not dissimilar to the prevalence of common conditions such
* Corresponding author.
E-mail address: yingcheong@hotmail.com (Y. Cheong).
1471-7697/$ see front matter # 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.rigp.2005.07.001
228
Table 1
Referred pain from the various somatic nerves are shown
Somatic nerve
Dermatome
Visceral field
Ilioinguinal
Genitofemoral
Lateral femoral cutaneous
Pudendal
L1-2
L1-2
L2-3
S2-4
229
3. Investigations
Investigations are undertaken so as to diagnose the
underlying pathology and we are guided by patients
presenting symptoms and our clinical findings in order to
arrange the appropriate investigations. It is a challenge
instigating the right investigations for patients with chronic
pelvic pain because there is a considerable overlap in
symptoms in patients with CPP. Using a postal questionnaire, Zondervan et al. [3] surveyed 3916 women
selected from the Oxfordshire Health Authority Register
(74% respond rate, n = 2304) and found that half the women
with CPP (n = 483) also had genitourinary symptoms or
irritable bowel syndrome, or both [10]. There was a higher
prevalence of dysmenorrhea and dyspareunia in women
with CPP (81% and 41%, respectively) compared with
women without CPP (58% and 14%, respectively). Among
all women with CPP, 34% reported that they had undergone
at least one investigation for pain but the proportion of
women who had investigations varied from 30% to 48%
depending on their presenting symptoms but women with
genitourinary symptoms or irritable bowel symptoms tends
to get more investigations compared to women with CPP
only. The reported investigations in descending order of
frequency were: ultrasonography (21.5%), laparoscopy or
laparotomy (11.2%), sigmoidoscopy or colonoscopy
(9.3%), radiography (7.2%) or others (4%). Among all
women with CPP, 20% reported that they never had any
investigations but had received a diagnosis. Among these
women, the most common diagnosis was irritable bowel
syndrome (46%), ovarian cysts (26%), endometriosis (21%)
and stress (20%).
4. Blood tests
Inflammatory markers are non-specific and may not be
raised in chronic pelvic inflammatory disease. There is
therefore very little value in performing these tests as the
primary investigations as they can be raised in many other
conditions non-contributory to the CPP. We do, however,
recommend testing for inflammatory markers such as Creactive proteins and leukocyte count in the case of an acute
exacerbation of CPP so as to exclude a fresh attack of pelvic
inflammatory disease (Fig. 3).
230
5. Radiological
5.1. Endometriosis
Transvaginal ultrasonography (TVS) is helpful in
assessing endometriotic ovarian cysts. On TVS, endometriomas appear as ovarian cysts with low level internal
echoes, multilocularity or hyperechoic wall foci. TVS,
however, has little value in assessing the presence of
adhesions and mild peritoneal deposits. In deep infiltrating
disease, where endometriosis involves the Pouch of
Douglas, often hypoechoic linear thickening, or nodules/
masses with or without regular contours can be seen on TVS,
occasionally infiltrating into organs or on the uterosacral
ligaments. The Pouch of Douglas can also be obliterated
with or without free fluid. Bazot et al. [34] examined 142
women with clinical signs of endometriosis with transvaginal scanning (TVS) in a prospective cohort study where
ultrasound findings were compared to surgical and
histological findings. They found that the sensitivity,
specificity, positive and negative predictive values of TVS
for predicting deep infiltrating pelvic endometriosis were
79%, 95%, 95% and 78%.
More recently, the role of endoanal ultrasound has been
evaluated for the diagnosis of deep infiltrating endometriosis. Delpy et al. [6] studied the use of anorectal
endoscopic ultrasonographic examination (EUS) in the
diagnosis of severe rectovaginal septum endoemtriosis in
30 patients. EUS showed the presence of rectovaginal
septum endometriosis in 26 patients (88%), in the
uterosacral ligaments in 10 patients (33%) and in the
ovaries in 2 patients (6%). Subsequent surgical exploration demonstrated RV septum endometriosis in 26 patients
(88%) and the uterosacral ligament in 22 (73%) cases, and
the ovaries in 6 (20%) cases. They concluded that EUS
has a sensitivity of 96%, specificity of 100%, positive
predictive value of 100% and negative predictive value of
83% in diagnosing endometriosis in the rectovaginal
septum [6].
It therefore appears that TVS and endoanal ultrasonography, in the right hands within an appropriate referral
population is reasonably accurate in diagnosing deeply
infiltrating posterior endometriosis although this degree of
accuracy may not be achievable in all units. More
importantly, although laparoscopy is the gold standard
for diagnosis of endometriosis, the correlation between
visible endometriosis and histological diagnosis can vary
[11,12]. As not all patients in these studies who have visible
endometriosis during laparoscopy have histologically confirmed endometriosis, the results may be confounded.
Further studies with larger sample sizes are needed to
confirm or refute the reliability and accuracy of routine use
of such radiological investigations for the diagnosis of deep
infiltrating pelvic endometriosis.
Adenomyosis is characterized by the presence of
heterotrophic endometrial glands and stroma in the
231
6. Endoscopic
6.1. Laparoscopy under local anaesthesia
Conscious laparoscopic pain mapping (CLPM) is a
diagnostic laparoscopy performed under local anaesthesia in
women with chronic pelvic pain (CPP); the objective is to
localise the sources of tenderness with the aid of the patient
when mechanical stimulus is applied to areas in the pelvis
and the pelvic organs. During CLPM, the advantage is that
the patient can be conscious and can therefore alert the
clinician to the site of tenderness, the assumption is made
that pain stimulus in CPP must be mechanical. This, in fact,
has not been fully supported by the literature. The pathophysiology of pain in CPP is often not mechanical. There is
little research on the actual effect of laparoscopy and
gaseous insufflations on pain perception. Furthermore, even
when pathology such as endometriosis is diagnosed, the pain
correlation with mechanical stimulus to the affected areas is
inconsistent [23].
However, the findings of CLPM can help to guide the
clinician as to the subsequent steps of management of CPP.
A clinical audit of all the women who underwent pain
mapping over the last 4 years in Southampton showed that
the number of women with tenderness over the following
areas in decreasing order of frequency were: ovaries and/or
uterus (38%, n = 15); generalised hyperalgesia, therefore
suggesting neuropathic pain (21%, n = 8); adhesions and
sterilisation clip (13%, n = 5); abdominal wall (8%, n = 3);
occult inguinal hernia (8%, n = 3); vaginal vault (5%, n = 2)
and others (5%, n = 2) [24]. As a result of the findings, we
are able to triage women who had CLPM in our study for
further surgery (41%, n = 16) further hormonal treatment
(28%, n = 11), further pain management via the multidisciplinary pain team 26% (n = 10) and 5% (n = 2) were
discharged back to the GP. Defining success as the
outcomes of benefit to the patient (Table 2), we concluded on
the basis of the case note review that 82% of the procedures
were successful. It should be noted that these audit findings
cannot be generalized to other settings and CLPM cannot be
recommended a routine investigation. In our clinical
practice, patients who are elect to undergo CLPM are a
specific sub-group where following a clinical history and
examination the assessment is that CLPM could (1) identify
a problem that can be resolvable by further surgery and/or
(2) demonstrate the presence of generalised non-localised
tenderness, a finding that may enable the patient to reorient
her goals towards pain management rather than a search for
specific focal pathology. No black and white rules exist in
the selection of these women for CLPM; rather the process is
seen as very much dependent on the consultation and the
goals and expectations of the individual patient. In
particular, given the unpleasantness of the procedure, it is
only to be considered when positively desired by the patient
after full counseling. The right theatre set-up with
appropriate anaesthetic support is required for the procedure
232
Table 2
Outcomes of CLPM: case note based rating of success and failure
% (n)
Success (n = 32)
Procedure identified a problem amenable to surgery and patient was better after recommended surgery
Procedure indicated that surgery was going to be unhelpful and patient had alternative therapy and got better
Patient was better informed and reassured
38 (15)
36 (14)
8 (3)
Failure (n = 4)
Adhesions were removed but no better
Failed attempt of embolisation of pelvic veins and patient lost to follow-up
CLPM suggested abdominal wall tenderness, local injection of area did not work
3 (1)
3 (1)
5 (2)
Equivocal (n = 3)
Patient got pregnant, therefore treatment stopped
Recommended surgery but patient lost to follow-up
3 (1)
5 (2)
233
234
Fig. 4. Illustration of a step down analgesia pain ladder used in Princess Anne Hospital, Southampton.
235
8. Conclusion
There are at present a multitude of investigational tools
for women with chronic pelvic pain. The choice of
investigations will depend on the patients clinical history,
symptoms. Although many of the investigations may not
reveal a diagnosis but the simple reassurance of the normal
results may be enough for some women. Perhaps we can say
that in the absence of a specific identifiable cause, CPP can
be considered a diagnostic category in its own right, as with
other types of chronic pain (i.e. pain is the disease). Many
clinicians suffer heart sink when they see women with
chronic pelvic pain. However, much can be done to improve
care for these women by taking a broad based approach.
Much lies in the clinicians insight into the condition,
individual attitudes towards women with CPP, and appropriate management and referrals. Time spend on the initial
consultation to delineate the problems and understand the
issues underlying the condition is time well spent.
References
[1] Howard F. The role of laparoscopy in the chronic pelvic pain patient.
Clin Obstet Gynaecol 1998;46(4):74966.
[2] Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF.
Chronic pelvic pain: prevalence, health related quality of life, and
economic correlates. Obstet Gynecol 1996;87:3217.
[3] Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG,
Barlow DH, et al. The community prevalence of chronic pelvic pain in
women with associated illness behaviour. Br J Gen Pract
2001;51:5417.
[4] Selfe SA, Van Vugt M, Stones RW. Chronic gynaecological pain: an
exploration of medical attitudes. Pain 1998;77(2):21525.
[5] Walker KG, Shaw RW. Endometriosis, pelvic pain and psychological
functioning. Fertil Steril 1995;63:796800.
[6] Delpy R, Barthet M, Gasmi M, Berdah S, Shojai R, Desjeux A, et al.
Value of endorectal ultrasonography for diagnosing rectovaginal
236
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21] Tarazov PF, Verdiev ND, Prozorovskie KV. Transcatheter embolization of ovarian vein varicosities. Vestn Khir Im I I Grek 2002;161(1):
904.
[22] Stones RW. Pelvic vascular congestion-half a century later. Clin Obstet
Gynecol 2003;46(4):8316.
[23] Almeida OD, Val-Gallas JM. Concious pain mapping. J Am Assoc
Gynecol Laparosc 1997;4:58790.
[24] Cheong YC, Al-Talib R, Stones RW. Role of conscious laparoscopic
pain mapping in the management of women with chronic pelvic pain.
In: Li, T., Ledger, W., editors. Pelvic pain. Sheffield: Taylor and
Francis Medical Books, in press.
[25] Swank DJ, Swank-Bordewijk SC, Hop WC, van Erp WF, Jenssen IM,
Bonjier HJ, et al. Laparoscopic adhesiolysis in patients with chronic
abdominal pain: a blinded randomised controlled multi-centre trial.
Lancet 2003;361(9365):124751.
[26] Alexander-Williams J. Do adhesions cause pain? Br Med J Clin Res
Ed 1987;294(6573):65960.
[27] Duffy D, diZerega G. Adhesion controversies: pelvic pain as a cause of
adhesions, crystalloids in preventing them. J Reprod Med 1996;41(1):
1926.
[28] Stones RW, Cheong YC, Horward F. Interventions for treating chronic
pelvic pain. The Cochrane Library in press;(3).
[29] Peters A, van Dorst E, Jellis B, van Zuuren E, Hermans J, Trimbos J. A
randomized clinical trial to compare two different approaches in
women with chronic pelvic pain. Obstet Gynecol 1991;77(5):7404.
[30] Kresch A, Seifer D, Sachs L, Barrese I. Laparoscopy in 100 women
with chronic pelvic pain. Obstet Gynecol 1984;64:6724.
[31] Kligman I, Drachenberg C, Papadimitriou J, Katz E. Immunohistochemical demonstration of nerve fibres in pelvic adhesions. Obstet
Gynecol 1993;82:5668.
[32] Tulandi T, Chen M, Al-Took S, Watkin K. A study of nerve fibers and
histopathology of postsurgical, postinfectious, and endometriosisrelated adhesions. Obstet Gynaecol 1998;92(5):7668.
[33] Sutton CJ, Pooley AS, Ewen SP, Haines P. Follow-up report on a
randomized controlled trial of laser laparoscopy in the treatment of
pelvic pain associated with minimal to moderate endometriosis. Fertil
Steril 1997;68:10704.
[34] Bazot M, Thomassin I, Hourani R, Cortez A, Darai E. Diagnostic
accuracy of transvaginal sonography for deep pelvic endometriosis.
Ultrasound Obstet Gynecol 2004;24:1805.